<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-143191</identifier>
<setSpec>1134-248X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Clinical research in fentanyl pectin nasal spray</dc:title>
<dc:description xml:lang="en">Despite adequate control of chronic cancer pain with major opioids, some patients experience transitory and intense exacerbations. These exacerbations, known as breakthrough pain, are characterized by rapid onset, short duration and strong intensity. Episodes of breakthrough pain require specific treatment with analgesics tailored to relieve this type of pain. Notable among these analgesics is a transmucosal nasal fentanyl formulation in a pectin-based gel (PecFent®), whose clinical development is summarized in this article (AU)</dc:description>
<dc:creator>Cabezón Gutiérrez, Luis</dc:creator>
<dc:creator>Khosravi Shahi, Parham</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">A pesar del tratamiento adecuado del dolor basal crónico con opioides mayores, determinados pacientes sufren exacerbaciones transitorias e intensas de inicio rápido, corta duración y gran intensidad denominadas dolor irruptivo. Este tipo de dolor requiere un tratamiento específico con analgésicos capaces de mimetizar las características del episodio de dolor irruptivo. Entre esos analgésicos destaca la formulación de fentanilo de absorción transmucosa nasal a base de pectina (PecFent®), cuyo desarrollo clínico se resume brevemente en este artículo (AU)</dc:description>
<dc:source>Med. paliat;22(supl.1): 57-61, mayo 2015. ilus, tab</dc:source>
<dc:identifier>ibc-143191</dc:identifier>
<dc:title xml:lang="es">Investigación clínica del fentanilo intranasal con pectina</dc:title>
<dc:subject>^d29500^s22073</dc:subject>
<dc:subject>^d9562^s22012</dc:subject>
<dc:subject>^d10353^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28037^s22078</dc:subject>
<dc:subject>^d28037^s22000</dc:subject>
<dc:subject>^d54692^s22045</dc:subject>
<dc:subject>^d715^s22073</dc:subject>
<dc:subject>^d54518^s22057</dc:subject>
<dc:subject>^d22320^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201505</dc:date>
</metadata>
</record>
</ibecs-document>
